Shaolin Capital Management »

Halozyme Therapeutics shares owned by Shaolin Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Shaolin Capital Management from 13F filings

Historical chart of Shaolin Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Shaolin Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Shaolin Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $2.1M 2.5M 0.85

More positions owned by Shaolin Capital Management

Palo Alto Networks Note 0.375% 6/0 (Principal)
On Semiconductor Corp Note 5/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dish Network Corporation Note 12/1 (Principal)
Cnx Res Corp Note 2.250% 5/0 (Principal)
Middleby Corp Note 1.000% 9/0 (Principal)
Splunk Note 1.125% 9/1 (Principal)
Zillow Group Note 0.750% 9/0 (Principal)
Smart Global Hldgs Note 2.250% 2/1 (Principal)
Ziff Davis Note 1.750%11/0 (Principal)
Pebblebrook Hotel Tr Note 1.750%12/1 (Principal)
Integra Lifesciences Hldgs C Note 0.500% 8/1 (Principal)
Dropbox Note 3/0 (Principal)
Lci Inds Note 1.125% 5/1 (Principal)
Microstrategy Cl A New (MSTR)

View all positions for Shaolin Capital Management

Top funds holding Halozyme Therapeutics

Wellesley Investment Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Citigroup
Aviva
Citadel Advisors
D. E. Shaw & Co
Wells Fargo & Company
Readystate Asset Management
Tenor Capital Management
Wolverine Asset Management
Victory Capital Management
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management

View all funds holding Halozyme Therapeutics